Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.11.10.687612

Genomic analysis of the probiotic candidate Bifidobacterium bifidum strain 900791 in the context of the B. bifidum pangenome

Abstract

BackgroundBifidobacterium bifidum is a key commensal bacterium in the human gut microbiota with recognized probiotic properties and health benefits. An underinvestigated strain called 900791, isolated from meconium of a Siberian infant and with a validated role in lactose tolerance, requires more understanding of the genomic basis of its potential probiotic functionality. MethodsWe performed whole genome sequencing of strain 900791 using hybrid sequencing (Illumina NextSeq and Nanopore). The genome was functionally annotated and compared against 228 B. bifidum genomes to elucidate probiotic determinants and evolutionary relationships. Antibiotic resistance profiling was conducted using three independent approaches, carbohydrate-active enzymes (CAZymes) were characterized using dbCAN analysis; additionally different markers for desired phenotypes in probiotics (such as adherence to epithelial cells, resistance to low pH, bile salts and oxidative stress, and the ability to produce bacteriocins) were also investigated. ResultsThe complete genome comprises 2.28 Mb with 62.43% G+C content, encoding 1,852 ORFs, 53 tRNAs, and three complete 16S rRNA genes. Phylogenomic analysis revealed 900791 belongs to a distinct clonal subgroup of nine closely related strains sharing almost identical allelic similarity (observed via cgMLST). The pangenome analysis of 229 B. bifidum genomes showed an open structure with 4,679 orthogroups, including 1,212 core families.The strain 900791 harbors extensive CAZymes from families GH2, GH20, GH33, and GH84 associated with mucin and human milk oligosaccharide degradation, plus GH2 and GH42 families for lactose metabolism. Safety assessment revealed only intrinsic resistance to mupirocin and rifampicin, with no acquired resistance markers or virulence factors. The strain possesses multiple stress tolerance systems including acid resistance (FF-ATPase), bile salt resistance (MFS transporters, BSH hydrolase), and oxidative stress response mechanisms. Predicted probiotic features include adhesion proteins (FimA/FimB, FimM), bacteriocin production capabilities, and comprehensive stress response systems. ConclusionB. bifidum 900791 harbors markers for significant probiotic potential with genetic features optimized for gut colonization, host interaction, and antimicrobial competition. This genomic characterization provides a framework for understanding B. bifidum diversity and supports B. bifidum strain 900791-specific probiotic applications, particularly given its demonstrated efficacy in improving lactose tolerance in human subjects.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Cardenas, J. P., Vidal-Veuthey, B., Meza, K., Almonacid, D. E., Gutkevich, A.. 2025-11-10. Genomic analysis of the probiotic candidate Bifidobacterium bifidum strain 900791 in the context of the B. bifidum pangenome. https://doi.org/10.1101/2025.11.10.687612

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A population-scale landscape of the subgingival microbiome reveals divergent routes to periodontal dysbiosis

Periodontitis is an archetypical mucosal inflammatory disease in which microbiome dysbiosis at the tooth-epithelial interface interacts with host genetic and behavioral risk factors to drive immune-mediated tissue destruction. Although subgingival microbiome compositional shifts are thought to parallel disease severity, microbiome variation at the population-level and its relationship to periodontal clinical phenotypes and disease-modifying factors remain poorly defined. Here, we use unsupervised manifold learning to map the compositional landscape of the subgingival microbiome in 1,355 adults spanning periodontal health to severe periodontitis. We identified eight latent microbiome states organized along a branching continuum from eubiosis to dysbiosis. An intermediate microbial configuration marked ecological destabilization and bifurcation into two distinct periodontitis-associated dysbiotic trajectories, distinguished by links to gingival inflammation and smoking. Although the microbiome trajectories broadly tracked periodontal destruction, a minority of individuals showed discordant microbiome-clinical phenotypes, with some individuals with periodontitis retaining otherwise eubiotic microbiomes enriched for low-abundance pathobionts, while some cases of health or mild disease had highly dysbiotic communities, suggesting distinct host susceptibility. Together, these findings define a population-scale ecological landscape of the subgingival microbiome, reveal divergent trajectories to periodontal dysbiosis, and highlight heterogeneity in the relationship between microbial community structure and clinical disease expression.

microbiology↗

Beta-lactam enhancement against methicillin-resistant Staphylococcus aureus by cell wall blockade is autolysis-dependent: a butyrolactone derivative as case in point

Methicillin-resistant Staphylococcus aureus (MRSA) is non-susceptible to beta-lactams. Blockade of cell wall biosynthesis is a potential target for beta-lactam enhancement but requires further investigation. A butyrolactone derivative enhanced beta-lactams against MRSA strains by reducing the availability of D-Ala-D-Ala. Unlike D-cycloserine, it did not inhibit D-Ala-D-Ala ligase (Ddl). Nor did it show an additive or synergistic effect when combined with cycloserine, indicating a unique mechanism for blocking cell wall precursor production that does not involve the traditional Lipid II pathway. Notably, beta-lactam potentiation by our chemical or D-cycloserine was highly dependent on the intrinsic autolytic ability of the tested MRSA strains. Strains that resisted lysis upon Triton X-100 exposure showed a minimal increase in beta-lactam susceptibility, whereas highly autolytic strains showed significant changes in their beta-lactam MICs. We have thus identified autolytic ability as the Achilles Heel in the strategy of targeting cell wall biosynthesis for beta-lactam potentiation.

microbiology↗

Rapid and largely reversible shifts in the canine fecal metabolome during dietary change

Diet can rapidly change the fecal metabolome, but less is known about recovery after the original diet is restored. We used untargeted UPLC-MS metabolomics to analyze 72 fecal samples from nine Pumi dogs during an owner-managed switch from dry food to raw food and back to dry food. Diet phase accounted for a large proportion of variation in both ionization modes. More than 13,000 LC-MS features changed at the first sampling point after the switch to raw food, with a similarly large response after return to dry food. Among features significant in both comparisons, more than 99% changed in opposite directions. At the final sampling point, no positive-mode (ESI+) features and only 13 negative-mode (ESI-) features differed from the second dry-food baseline under the same threshold. BARF-associated patterns persisted in analyses excluding individual dogs and in pedigree-adjusted candidate models, although individual feature effects depended on normalization. Putative metabolites from several biochemical classes differed in their response and recovery. The fecal metabolome therefore changed rapidly and returned largely toward baseline, with differences among dogs.

microbiology↗